PTCT is currently covered by 10 analysts with average potential upside of $14.21 (40.47%) backed by 123 price targets and 170 ratings. Documented since 15-Jul-2013. Analyst's average stock valuation to be materialised ratio is 65.66% with an average time for price targets to be met of 208.19 days.
Most recent stock forecast was given by DANIELLE BRILL from RAYMOND JAMES on 23-Feb-2023.
Highest price target for PTCT is 55, Lowest price target is 28, average price target is 41.5.
Currently, out of the existing stock ratings of PTCT - 1 which are a Sell (3.33%), 20 which are a Hold (66.67%), 9 which are a Buy (30%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
55
$10.83 (24.52%)
60
1 months 4 days ago
1/5 (20%)
$10.68 (23.15%)
87
Hold
48
$3.83 (8.67%)
48
1 months 5 days ago
17/18 (94.44%)
$12.06 (32.91%)
241
Hold
46
$1.83 (4.14%)
60
4 months 27 days ago
18/19 (94.74%)
$3.22 (9.14%)
139
Buy
76
9 months 6 days ago
1/3 (33.33%)
$22.97 (82.90%)
689
Hold
45
$0.83 (1.88%)
50
9 months 6 days ago
4/4 (100%)
$2.69 (12.31%)
70
What is PTCT(PTC Therapeutics, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on PTCT(PTC Therapeutics, Inc) with a proven track record?
